NDC 0409-2122

ENALAPRILAT

Enalaprilat

ENALAPRILAT is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Enalaprilat.

• Product ID: 0409-2122_3a7cb911-f52d-49b2-bd8a-cf4d88f6be87
• NDC: 0409-2122
• Product Type: Human Prescription Drug
• Proprietary Name: ENALAPRILAT
• Generic Name: Enalaprilat
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2005-08-24
• Marketing Category: ANDA / ANDA
• Application Number: ANDA075458
• Labeler Name: Hospira, Inc.
• Substance Name: ENALAPRILAT
• Active Ingredient Strength: 1 mg/mL
• Pharm Classes: Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 0409-2122-02

1 VIAL in 1 CARTON (0409-2122-02) > 2 mL in 1 VIAL

• Marketing Start Date: 2005-08-24
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0409-2122-02 [00409212202]

ENALAPRILAT INJECTION, SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA075458
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2005-08-24

NDC 0409-2122-01 [00409212201]

ENALAPRILAT INJECTION, SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA075458
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2007-01-03

NDC 0409-2122-13 [00409212213]

ENALAPRILAT INJECTION, SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA075458
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2005-04-30
• Marketing End Date: 2016-07-01

NDC 0409-2122-88 [00409212288]

ENALAPRILAT INJECTION, SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA075458
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2005-04-30
• Marketing End Date: 2016-03-01

Drug Details

Active Ingredients

Ingredient	Strength
ENALAPRILAT	1.25 mg/mL

OpenFDA Data

• SPL SET ID: c4d98e3c-bd7d-4076-be9e-00b98cf36935
• Manufacturer:
  • Hospira, Inc.
• UNII:
  • GV0O7ES0R3
• RxNorm Concept Unique ID - RxCUI:
  • 1729205
  • 1729200

Pharmacological Class

• Angiotensin Converting Enzyme Inhibitor [EPC]
• Angiotensin-converting Enzyme Inhibitors [MoA]
• Decreased Blood Pressure [PE]

NDC Crossover Matching brand name "ENALAPRILAT" or generic name "Enalaprilat"

NDC	Brand Name	Generic Name
0143-9786	Enalaprilat	enalaprilat
0143-9787	Enalaprilat	enalaprilat
0409-2122	ENALAPRILAT	ENALAPRILAT
0703-8401	Enalaprilat	Enalaprilat
0703-8411	Enalaprilat	Enalaprilat
51662-1477	ENALAPRILAT	ENALAPRILAT